Shenzhen University Medical Center, Shenzhen University Health Science Center, Shenzhen 518060, China.
Department of Biology, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Molecules. 2019 Jan 9;24(2):230. doi: 10.3390/molecules24020230.
In recent years, metabolic disorder, especially fatty liver disease, has been considered a major challenge to global health. The attention of researchers focused on expanding knowledge of the regulation mechanism behind these diseases and towards the new diagnostics tools and treatments. The pathophysiology of the fatty liver disease is undoubtedly complex. Abnormal hepatic lipid accumulation is a major symptom of most metabolic diseases. Therefore, the identification of novel regulation factors of lipid metabolism is important and meaningful. As a new diagnostic tool, the function of microRNAs during fatty liver disease has recently come into notice in biological research. Accumulating evidence supports the influence of miRNAs in lipid metabolism. In this review, we discuss the potential role of miRNAs in liver lipid metabolism and the pathogenesis of fatty liver disease.
近年来，代谢紊乱，尤其是脂肪肝疾病，被认为是对全球健康的主要挑战。研究人员的注意力集中在扩展这些疾病背后的调控机制的知识上，并针对新的诊断工具和治疗方法。脂肪肝疾病的病理生理学无疑是复杂的。异常的肝脂质积累是大多数代谢疾病的主要症状。因此，鉴定脂质代谢的新型调控因子是重要且有意义的。作为一种新的诊断工具，微小 RNA 在脂肪肝疾病中的功能在最近的生物学研究中受到了关注。越来越多的证据支持 miRNA 在脂质代谢中的影响。在这篇综述中，我们讨论了 miRNA 在肝脂质代谢和脂肪肝疾病发病机制中的潜在作用。
